NEW YORK (Reuters Health) – For women with breast cancer metastatic to bone, treatment with zoledronic acid to reduce skeletal complications does not prolong progression-free survival or overall…
NEW YORK (Reuters Health) – A single dose of oral azithromycin reduces the recurrence of trichiasis for up to three years more so than a six-week regimen of…
NEW YORK (Reuters Health) – Among patients with early stage non-small-cell lung cancer, treatment with gemcitabine and cisplatin before radical surgery is associated with better survival than is…
NEW YORK (Reuters Health) – Bone loss in postmenopausal women taking adjuvant letrozole for early breast cancer can be prevented with administration of zoledronic acid, investigators report in…
NEW YORK (Reuters Health) – Older patients with advanced hematologic malignancies and comorbid conditions can successfully undergo nonmyeloablative allogeneic hematopoietic cell transplantation (HCT), results of a new study…
NEW YORK (Reuters Health) – After organ transplantation, the overall risk of any new malignancy doubles, according to a new report from the U.S. National Cancer Institute. The…
NEW YORK (Reuters Health) – For women with advanced breast cancer, capecitabine provides similar overall survival with less toxicity compared with classical cyclophosphamide, methotrexate, and fluorouracil (CMF) first-line…
NEW YORK (Reuters Health) – Nail bed hemorrhage may serve as a clinical marker of optic disc hemorrhage in patients with glaucoma, researchers from South Korea report in…
The Cancer Foundation for Personal Appearance celebrates its 10th Anniversary! Congratulations to Joseph Minniti, Founder and Director, and to everyone at the foundation who has made a difference…
NEW YORK (Reuters Health) – The diagnostic yield of transbronchial biopsy of pulmonary nodules is improved when bronchoscopy is guided by various techniques, and the risk of pneumothorax…